Tubular MYDGF Slows Progression of Chronic Kidney Disease by Maintaining Mitochondrial Homeostasis
Authors:
Open Access
- 26 November 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 12 (3) , e2409756
Abstract
Mitochondrial dysfunction is a key event driving the maladaptive repair of tubular epithelial cells during the transition from acute kidney injury to chronic kidney disease (CKD). Therefore, identifying potential targets involved in mitochondrial dysfunction in tubular epithelial cells is clinically important. Myeloid‐derived growth factor (MYDGF), a novel secreted protein, plays important roles in multiple cardiovascular diseases, but the function of MYDGF in tubular epithelial cells remains unknown. In the present study, it is found that MYDGF expression is significantly reduced in the cortex of the kidney, especially in the proximal tubules, from mice with CKD. Notably, lower expression of MYDGF is observed in tubules from patients with CKD and the level of MYDGF correlated with key factors related to kidney fibrosis and estimated glomerular filtration rate (eGFR) in patients with CKD. Tubule‐specific deletion of Mydgf exacerbates kidney injury in mice with CKD; however, Mydgf overexpression attenuates kidney fibrosis by remodeling mitochondrial homeostasis in tubular epithelial cells. Mechanistically, renal tubular MYDGF positively regulates the expression of isocitrate dehydrogenase 2 (IDH2), restores mitochondrial homeostasis, and slows CKD progression. Thus, this study indicates that MYDGF derived from tubules may be an effective therapeutic strategy for patients with CKD.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2019BH030, ZR2019ZD40)
- National Natural Science Foundation of China (82090021, T2321004, 82090024)
This publication has 36 references indexed in Scilit:
- Uremic Toxin Receptor AhR Facilitates Renal Senescence and Fibrosis via Suppressing Mitochondrial BiogenesisAdvanced Science, 2024
- Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylationCell Metabolism, 2024
- Myeloid-derived growth factor and its effects on cardiovascular and metabolic diseasesCytokine & Growth Factor Reviews, 2023
- MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney diseaseDiabetologia, 2020
- FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagyCancer Letters, 2020
- Chronic Kidney Disease Diagnosis and ManagementJAMA, 2019
- MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylationKidney International, 2019
- IDH2 deficiency increases the liver susceptibility to ischemia-reperfusion injury via increased mitochondrial oxidative injuryRedox Biology, 2018
- Renal tubule injury: a driving force toward chronic kidney diseaseKidney International, 2018
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic ReprogrammingCancer Cell, 2012